The View Under the Microscope: Biopsy and Biology
At a Glance
An LMX1B nephropathy biopsy may look normal early or show FSGS on light microscopy. Electron microscopy can reveal an irregular, moth-eaten GBM and type III collagen, while immunofluorescence is usually negative; these clues support but do not replace genetic testing.
When a doctor performs a kidney biopsy, they are looking for the microscopic “fingerprints” of a disease. In isolated LMX1B-associated nephropathy, these prints can be very subtle and require careful interpretation alongside genetic results [1][2].
A Simplified Biological Mechanism
To understand the biopsy, you first have to understand the LMX1B gene’s job. In the kidney, this gene acts as a transcriptional regulator for podocytes—the sophisticated cells that wrap around your kidney’s tiny blood filters (glomeruli) to prevent protein from leaking into your urine [3][4].
When the LMX1B gene is mutated, the gene program for the podocyte is disrupted, affecting proteins such as NPHS1 (which makes nephrin) and WT1 [4][5]. Without these proteins, the podocytes cannot maintain the filter properly. The blueprint for the filter’s foundation, the Glomerular Basement Membrane (GBM), also becomes flawed [2][6].
What the Biopsy Shows
A kidney biopsy is examined in three different ways. In LMX1B-associated disease, each “view” provides supportive clues.
1. Light Microscopy (The Wide View)
This view often shows generic patterns of damage [1].
- Minimal Change: In the early stages, the kidney may look almost normal [1][7].
- FSGS: As the disease progresses, it often shows a pattern of Focal Segmental Glomerulosclerosis (FSGS)—a pattern of scarring that looks similar to immune-mediated FSGS [1][6].
2. Immunofluorescence (The “Glow” Test)
This test looks for antibodies or immune deposits. In this condition, the test is usually negative or shows nonspecific staining [8]. Positive or “pauci-immune” results require specialist interpretation and could indicate a coexisting condition [8].
3. Electron Microscopy (The Deep View)
This is where supportive specific clues may be found. Pathologists look for:
- Moth-Eaten Appearance: The GBM may look irregular, with clear spots that resemble a moth-eaten sweater [1][6].
- Type III Collagen: Finding bundles of type III collagen inside the filter wall is a strong supportive clue for an LMX1B mutation [2][9].
- Foot-Process Effacement: The “feet” of the podocytes appear flattened, which is common in many proteinuric diseases [10][1].
These findings are supportive; they are not required, and their absence does not exclude a genetically confirmed diagnosis.
Potential Diagnostic Mimics
The biopsy can sometimes provide differential clues:
- Fabry Disease or Medications: Sometimes, pathologists see small structures called myelin figures or zebra bodies [6][11]. These can appear in Fabry disease, from certain medications, or in LMX1B-associated nephropathy [11][12].
- Alport Syndrome: Because both conditions affect the collagen in the kidney filter, the thinning or fraying of the filter wall can sometimes look like Alport Syndrome [13][14].
Pathology Report Checklist
When reviewing your biopsy report, you can ask your renal pathologist about:
Common questions in this guide
What changes might appear on a kidney biopsy with LMX1B nephropathy?
Does negative immunofluorescence rule out LMX1B-associated nephropathy?
What does type III collagen in the glomerular basement membrane mean?
Can zebra bodies on a kidney biopsy have causes other than LMX1B nephropathy?
Does the absence of a moth-eaten glomerular basement membrane rule out LMX1B nephropathy?
How do minimal change disease and FSGS fit into an LMX1B biopsy report?
Get notified when new evidence is published on Nail-patella-like renal disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Clinical and histological findings of autosomal dominant renal-limited disease with LMX1B mutation.
Konomoto T, Imamura H, Orita M, et al.
Nephrology (Carlton, Vic.) 2016; (21(9)):765-73 doi:10.1111/nep.12666.
PMID: 26560070 - 2
LMX1B-Associated Nephropathy With Type III Collagen Deposition in the Glomerular and Tubular Basement Membranes.
Andeen NK, Schleit J, Blosser CD, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(2)):296-301 doi:10.1053/j.ajkd.2017.09.023.
PMID: 29246420 - 3
Spectrum of LMX1B mutations: from nail-patella syndrome to isolated nephropathy.
Harita Y, Kitanaka S, Isojima T, et al.
Pediatric nephrology (Berlin, Germany) 2017; (32(10)):1845-1850 doi:10.1007/s00467-016-3462-x.
PMID: 27450397 - 4
Dysregulation of WTI (-KTS) is Associated with the Kidney-Specific Effects of the LMX1B R246Q Mutation.
Hall G, Lane B, Chryst-Ladd M, et al.
Scientific reports 2017; (7()):39933 doi:10.1038/srep39933.
PMID: 28059119 - 5
Nail-patella syndrome.
Witzgall R
Pflugers Archiv : European journal of physiology 2017; (469(7-8)):927-936 doi:10.1007/s00424-017-2013-z.
PMID: 28681095 - 6
LMX1B-associated nephropathy that showed myelin figures on electron microscopy.
Shimohata H, Miyake Y, Yoshida Y, et al.
CEN case reports 2021; (10(4)):588-591 doi:10.1007/s13730-021-00612-y.
PMID: 34076843 - 7
Focal segmental glomerulosclerosis associated with undescribed mutation in the LMX1B gene.
Martín Gómez MA, Caba Molina M, León Fradejas M, et al.
European journal of medical genetics 2024; (72()):104980 doi:10.1016/j.ejmg.2024.104980.
PMID: 39490407 - 8
Case report: dual pathology of LMX1B-associated nephropathy and iga nephropathy in a middle-aged woman.
Sajjad A, Amer R, Alsayed M, et al.
BMC nephrology 2026; (27(1)).
PMID: 41992156 - 9
Collagenofibrotic Glomerulopathy.
Miyake M, Katayama K, Ehara T, et al.
Internal medicine (Tokyo, Japan) 2021; (60(6)):911-915 doi:10.2169/internalmedicine.6090-20.
PMID: 33055489 - 10
Clinicopathological characteristics and cyclosporine-responsive proteinuria in nail-patella syndrome with a novel LMX1B mutation.
Jiang L, Feng S, Xu Z, et al.
Pediatric nephrology (Berlin, Germany) 2026; (41(4)):1013-1024 doi:10.1007/s00467-025-07036-1.
PMID: 41249554 - 11
Myelin bodies in LMX1B-associated nephropathy: potential for misdiagnosis.
Lei L, Oh G, Sutherland S, et al.
Pediatric nephrology (Berlin, Germany) 2020; (35(9)):1647-1657 doi:10.1007/s00467-020-04564-w.
PMID: 32356190 - 12
Nail-patella-like renal disease masquerading as Fabry disease on kidney biopsy: a case report.
Pinto E Vairo F, Pichurin PN, Fervenza FC, et al.
BMC nephrology 2020; (21(1)):341 doi:10.1186/s12882-020-02012-3.
PMID: 32791958 - 13
A case of concurrent Alport syndrome and Nail-patella syndrome posing diagnostic challenge without genetic testing.
Fung WW, Yau ML, Lam PPH, et al.
BMC nephrology 2025; (26(1)):668 doi:10.1186/s12882-025-04606-1.
PMID: 41299396 - 14
A Novel Mutation in LMX1B (p.Pro219Ala) Causes Focal Segmental Glomerulosclerosis with Alport Syndrome-like Phenotype.
Oe Y, Mishima E, Mori T, et al.
Internal medicine (Tokyo, Japan) 2021; (60(18)):2991-2996 doi:10.2169/internalmedicine.6987-20.
PMID: 33814499
This page explains how biopsy findings may support an LMX1B-associated nephropathy diagnosis, but it cannot interpret your individual report. Discuss your results with a nephrologist or renal pathologist; this information is educational and does not constitute medical advice.